|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | |
| A61K 47/50 | |||
| A61K 45/06 | |||
| A61P 35/00 |
| (11) | Number of the document | 2644204 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13158391.6 |
| Date of filing the European patent application | 2009-03-10 | |
| (97) | Date of publication of the European application | 2013-10-02 |
| (45) | Date of publication and mention of the grant of the patent | 2017-04-19 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 37410 P | 2008-03-18 | US |
| (72) |
Berry, Leanne, US
Phillips, Gail, Lewis, US
Sliwkowski Mark, X., US
|
| (73) |
Genentech, Inc.,
1 DNA Way, South San Francisco, CA 94080,
US
|
| (54) | Combinations of an Anti-HER2 antibody-drug conjugate and pertuzumab |
| Combinations of an Anti-HER2 antibody-drug conjugate and pertuzumab |